Literature DB >> 22970036

Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis.

Koji Yamanoi1, Masaki Mandai, Ayako Suzuki, Noriomi Matsumura, Tsukasa Baba, Yumiko Yoshioka, Kenzo Kosaka, Ikuo Konishi.   

Abstract

In an attempt to clarify the clinical characteristics of synchronous primary endometrial and ovarian cancer (SPC), we reviewed the clinicopathological features of 13 cases treated in the Department of Gynecology and Obstetrics at Kyoto University Hospital over the last 6 years and compared them with 186 cases of primary uterine corpus cancer (PCC) and 136 cases of primary ovarian cancer (POC). Comparisons were performed based on clinicopathological factors, including age, BMI, parity, complication of thrombosis and FIGO stage. For SPC patients, the mean age was 51.5 years; 6 (46%) were nulliparous, and 7 (53%) had complicated thrombosis. All had well-differentiated endometrial cancer and 12 (92%) had endometrioid cancer in the ovary. The mean age of the SPC patients was significantly lower than that of the PCC patients (51.5 vs. 58.9 years). Thrombosis occurred in the SPC patients at a significantly higher rate than in both the PCC and POC patients. When the incidence of endometriosis and the regularity of menstruation were compared between patients who developed SPC with those who develop PCC at a young age (under 45 years), the SPC patients exhibited a significantly higher rate of endometriosis (100 vs. 35%), whereas the PCC patients exhibited a higher rate of irregular menstruation (53 vs. 15%, p=0.05). As for thrombosis, the age and FIGO stage of thrombosis-positive patients were significantly higher than those of thrombosis-negative patients in PCC and POC, while in SPC patients there was no such difference. In conclusion, this study demonstrated the differences in clinical features between SPC and PCC, and also novel features of SPC, namely endometriosis and thrombosis, which are essential in the management of this disease.

Entities:  

Year:  2012        PMID: 22970036      PMCID: PMC3439173          DOI: 10.3892/ol.2012.770

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

Review 1.  Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis.

Authors:  N C Denko; A J Giaccia
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

Review 2.  Endometriosis.

Authors:  Linda C Giudice; Lee C Kao
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

3.  Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types.

Authors:  R C Stern; R Dash; R C Bentley; M J Snyder; A F Haney; S J Robboy
Journal:  Int J Gynecol Pathol       Date:  2001-04       Impact factor: 2.762

4.  Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

Authors:  S Komiyama; D Aoki; E Tominaga; N Susumu; Y Udagawa; S Nozawa
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

5.  Synchronous primary cancers of the female reproductive tract in Turkish women.

Authors:  Sultan Eser; Ibrahim Gulhan; Raziye Özdemir; Nilgun Dicle; Merih Hanhan; Ali Baloglu; Aydin Ozsaran; Ugur Saygili
Journal:  Asian Pac J Cancer Prev       Date:  2011

6.  Risk factors for synchronous primary endometrial and ovarian cancers.

Authors:  L J Herrinton; L F Voigt; N S Weiss; S A Beresford; P A Wingo
Journal:  Ann Epidemiol       Date:  2001-11       Impact factor: 3.797

Review 7.  Thrombosis and cancer: Trousseau syndrome revisited.

Authors:  Maria Benedetta Donati
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

8.  Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.

Authors:  D S McMeekin; R A Burger; A Manetta; P DiSaia; M L Berman
Journal:  Gynecol Oncol       Date:  1995-10       Impact factor: 5.482

9.  Synchronous ovarian and endometrial carcinoma: a strong link to endometriosis?

Authors:  A Kondi-Pafiti; D Grapsa; A Liapis; K Papadias; E Kairi-Vassilatou; D Hasiakos
Journal:  Eur J Gynaecol Oncol       Date:  2008       Impact factor: 0.196

10.  Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.

Authors:  K Yamaguchi; M Mandai; T Oura; N Matsumura; J Hamanishi; T Baba; S Matsui; S K Murphy; I Konishi
Journal:  Oncogene       Date:  2010-01-11       Impact factor: 9.867

View more
  3 in total

Review 1.  Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.

Authors:  Jeong-Yeol Park; Joo-Hyun Nam
Journal:  Oncologist       Date:  2015-02-11

2.  Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

Authors:  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

3.  A Case of Synchronous Primary Corpus and Ovarian Cancer with Pseudo-Meigs Syndrome: Utilization of a Diagnostic Laparoscopy for the Accurate Diagnosis.

Authors:  Shimpei Shitanaka; Koji Yamanoi; Jumpei Ogura; Tsutomu Ohara; Yoshihide Inayama; Takahiro Hirayama; Mie Sakai; Haruka Suzuki; Koji Yasumoto; Koh Suginami
Journal:  Gynecol Minim Invasive Ther       Date:  2019-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.